Levothyroxine Linked to Increased Bone Loss: A study

Overview

A recent study has identified a link between levothyroxine, a widely prescribed thyroid medication, and increased bone loss. This is concerning for patients already at risk of osteoporosis.¹

Dr Bhaskar Jain, Senior Consultant, Endocrinology, explains, “While levothyroxine is essential for managing hypothyroidism, excessive doses can have some consequences on bone health.”

Thyroid Hormones and Bone Health

Thyroid hormones play a crucial role in regulating metabolism, growth, and bone remodelling. The primary hormone, thyroxine (T4), is converted into triiodothyronine (T3), directly affecting bone turnover. According to the Cleveland Clinic, the thyroxine (T4) test is critical in diagnosing and managing thyroid imbalances.²

Excess thyroid hormone, whether from hyperthyroidism or overtreatment with levothyroxine, accelerates bone resorption. This imbalance leads to weaker bones and increases the risk of fractures .³

Dr. Jain adds, “Bone remodelling is a delicate process. Disruptions caused by hormonal imbalances can tip the scale towards bone loss, especially in vulnerable populations like postmenopausal women.”

Key Findings from the Study

Recent research at the Radiological Society of North America (RSNA) 2024 meeting highlights a clear correlation between long-term levothyroxine use and reduced bone mineral density. The study involved over 2,000 participants and used advanced imaging techniques to measure bone density in various age groups.¹

One of the most important findings was the increased prevalence of osteoporosis in women over 50 who had been on levothyroxine for over five years. Women in their menopause age are already prone to bone loss due to hormonal changes.

Another research published in the Journal of Clinical Endocrinology & Metabolism confirms the relationship between prolonged levothyroxine therapy and reduced bone mineral density. A meta-analysis of over 15 studies revealed that patients receiving higher doses of levothyroxine had significantly lower bone mineral density, particularly in the lumbar spine and femoral neck.⁴

Mechanisms Behind Bone Loss

Bone remodelling is a natural process involving bone resorption and formation. In healthy adults, this cycle maintains bone strength. However, excessive thyroid hormone disrupts this balance, favouring resorption.

According to the International Osteoporosis Foundation, high levels of thyroid hormones increase the activity of osteoclasts, the cells responsible for bone breakdown. Over time, this leads to significant bone loss and a higher risk of fractures.³

Dr Jain remarks, “Over-supplementation can be just as harmful as under-treatment when it comes to thyroid management.”

Clinical Role

For medical professionals, these findings tell about the importance of careful monitoring when prescribing levothyroxine. Regular bone density tests, particularly for high-risk groups, can help identify early signs of osteoporosis.

Patients should also be informed about lifestyle modifications to support bone health. These include:

• Adequate calcium and vitamin D intake.
• Weight-bearing exercises.
• Avoiding smoking and excessive alcohol consumption.

“Active measures such as routine bone density scans and lifestyle interventions can significantly reduce fracture risks,” Dr Jain advises.

Patient Awareness and Safety

All managing thyroid conditions need to understand the potential risks. Levothyroxine remains a critical medication for hypothyroidism, but proper dosing is essential. Over-supplementation can harm bone health.

Dr. Jain says, “Patients should not stop or adjust their medication without consulting their doctor. Care and regular check-ups are key to get the best outcomes.”

Conclusion

The link between levothyroxine and bone loss highlights the need for a balanced approach to thyroid management. By regular monitoring and patient education, healthcare providers can avoid risks while giving effective treatment. Further research is required to know more about thyroid disorders therapy without compromising bone health.

References

1. RSNA 2024 Meeting Central [Internet]. [cited 2024 Dec 30]. Available from: https://reg.meeting.rsna.org/flow/rsna/rsna24/MeetingCentralRSNA24/page/session-catalog/session/1719959927225003C9tp.
2. T4 (Thyroxine) Test: What It Is, Function, Purpose & Levels. Cleveland Clinic [Internet]. [cited 2024 Dec 30]. Available from: https://my.clevelandclinic.org/health/diagnostics/24235-thyroxine-t4-test.
3. https://www.osteoporosis.foundation/health-professionals/about-osteoporosis/pathophysiology
4. Ku EJ, Yoo WS, Lee EK, Ahn HY, Woo SH, Hong JH, et al. Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism [Internet]. 2021 [cited 2024 Dec 30]; dgab539. Available from: https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgab539/6327817.